Department of Pharmaceutical Science, Loknete Dr. J. D. Pawar College of Pharmacy, Manur, Tal. Kalwan.
Orally administered non-solution dosage forms are subjected to in vitro performance studies, similar to dissolution tests, for several reasons. This test is one of the routine quality control procedures for oral solid dosage forms. Since its inception as a branch of physical chemistry approximately a century ago, the study of dissolution has advanced significantly. In order to forecast the drug's in vivo bioavailability and to assure consistent product quality, dissolution testing is mostly utilized for biopharmaceutical characterization of the therapeutic product. It has now been used in other more recent dose forms, but it was first created for solid orals. The dissolving device calculates how quickly a medicine dissolves in a particular liquid. In pharmaceutical quality control, it is a crucial instrument. One of the elements influencing the safety and effectiveness of pharmaceuticals is their ability to achieve the required dissolution profiles, which is ensured by regulatory agencies utilizing the equipment. The pharmacopoeias of the United States and India outline uniform procedures and equipment for dissolve testing in order to guarantee consistent medication release and consequent bioavailability. Both IP and USP make reference to variables such the dissolving fluid volume, medium temperature, and rotational speed. Within the cylindrical basket of the basket equipment, the drug's dose form is inserted. Conversely, the Paddle apparatus functions by use of a revolving paddle that stirs the drug dissolving media.
In -vitro dissolving equipment, the rate at which a medication dissolves in a solution that mimics its behaviour in the gastrointestinal tract from a dosage form like tablets or capsules may be measured. Indian Pharmacopoeia (IP) and United States Pharmacopoeia (USP) are two of the most significant international standards used in dissolution testing. Pharmacopeia uses dissolution testing to measure medication release from solid and semisolid dosage forms. Dissolution is crucial for assessing drug release in various dosage forms, including tablets, capsules, and aerosols. Physical chemists have been studying dissolution since the late 19th century, aiming to conduct performance tests for various USP dosage formulations.[1] Official dissolution equipment come under seven types. They are according to USP 30: United States Pharmacopoeia Apparatuses. These include: (Basket) Apparatus1, (Paddle) Apparatus 2, (Reciprocating) Apparatus 3, (Flow-Through Cell) Apparatus 4, (Paddle Over Disk) Apparatus 5, (Rotating Cylinder) Apparatus 6, (Reciprocating Holder) Apparatus 7. The Indian Pharmacopoeia uses two apparatuses, IP Paddle and Basket, while British, Japanese, and European Pharmacopoeia's apparatuses 1, 2, and 4 are official.[2] In-vitro dissolution testing is a crucial method in the pharmaceutical industry for determining the release speed of active ingredients from dosage forms, predicting their human body behavior.[3] The development of in-vitro dissolving equipment is motivated by the need for quality control in drug research and production. These tools assist in identifying drug releases. Features include testing the generic medications against their branded equivalents and guaranteeing consistency from batch to batch. USP dissolution tests, specified in monographs, evaluate product performance using specific apparatuses. USP training and services improve quality standards for regulatory compliance, using reciprocating cylinder, basket, paddle, and flow-through cell.[4]
The role of dissolution testers, also known as a dissolution apparatus or dissolution testing equipment, would generally be to determine the rate and extent to which drugs are dissolved from solid dosages forms, for instance tablets or capsules, in a liquid medium under specified conditions. This dissolution tester was an important quality control tool in the drug development, optimization, and manufacturing process of the pharmaceutical tablets for reproducible and consistent release of the active pharmaceutical ingredient. Conventionally, a dissolution tester is made up of various vessels or cells containing the tablets or capsules and a mechanism for agitating the liquid medium most commonly water or a buffer solution to ensure uniform conditions in the dissolution test. The design of the dissolution tester should aim at replicating physiological conditions that are prevalent in the gastrointestinal tract in which the tablets or capsules must dissolve the API upon administration.[5]
Functions Of Dissolution Tester:
Dissolution apparatus is utilized in pharmaceutical testing to evaluate the rate and efficiency of an API's dissolution in a solution. Indian Pharmacopeia and United States Pharmacopeia have standardized guidelines for these instruments to make sure proper measurements are made across the pharmaceutical industry. The major parts of the IP and USP testers include:
Apparatus 2-USP/IP Paddle Apparatus A paddle shall be balanced to be used for the pre - mixing of the dissolving agent.
Basket Apparatus (Apparatus 1 - USP/IP): A wire mesh basket is used as a vessel in which the dosage form is placed.
Table No 1 : Dissolution Apparatus
|
IP |
USP |
Apparatus 1 |
Paddle apparatus |
basket apparatus |
Apparatus 2 |
basket apparatus |
Paddle apparatus |
Apparatus 3 |
|
Reciprocating cylinder apparatus |
Apparatus 4 |
|
Flow-through cell apparatus |
Apparatus 5 |
|
Paddle over disk type apparatus |
Apparatus 6 |
|
Cylinder type apparatus |
Apparatus 7 |
|
Reciprocating disk type apparatus |
5.Indian Pharmacopoeia Dissolution Apparatus:
A paddle type dissolving apparatus measures the rate at which drugs dissolve from tablets and capsules in liquid media, mimicking stomach mechanical agitation. The IP Type 1 and USP Apparatus 2 are commonly used in pharmaceutical testing to monitor dosage forms. The Indian Pharmacopoeia compendium requires two dissimilar apparatuses for dissolution tests.[7]
Procedures:
Components:
ADVANTAGES:
DISADVANTAGES:
Basket Type 2 Apparatus
It closely looks like Apparatus 1. However, the paddle, which is the stirring elements, is replaced with a basket. There is much slick rotation in the metal shaft. The top end of the basket a fitted for a three spring clips. The bottom detachable portion is composed of welded steam cloth that has 0.381mm apparatus, which has been formed into a cylinder.[7] The basket assembly includes a woven basket with a rotating metallic shaft, a dissolution medium with a PH range of 0.05 units, and a sample withdrawn at predetermined intervals. The basket must be gold-coated and 2.5 µm thick, with a space between the basket and vessel's bottom between 23 and 27 mm. The mesh integrity should be examined using a microscope. A water bath or heating apparatus can maintain the medium's temperature. Conventional tablet dissolution approval requirements are listed in Table 1.2.[8]
Table No 2 : IP Acceptance criteria for dissolution test
S1 |
6 tablets |
At least D+ 5 percent
|
S2 |
6 tablets |
12 units (s1 + s2) above D on average, and no unit < D>
|
S3 |
12 tablets |
AV 24 units ? D NMT 2 units less than D – 15 percents and non < 25> |
Procedures:
ADVANTAGES:
DISADVANTAGES:
Figure No 3 : Basket Apparatus
United States Pharmacopoeia Dissolution Apparatus
The USP dissolution apparatus measures the speed of a medicine's dissolution in liquid media, ensuring consistent drug performance and bioavailability. Different types of devices are developed for different drug formulations or release mechanisms.[10]
USP Dissoluttion Apparatus:
Table No 3 : USP Dissolution Apparatus
Apparatus |
Type |
Rotation speed (RPM) |
Dosage form
|
Apparatus 1 |
Basket Apparatus |
50-120
|
Conventional tablets, Chewable tablets, Controlled release
|
Apparatus 2 |
Paddle Apparatus |
25-50
|
Orally disintegrating tablets, Chewable tablets, Controlled release, Suspension |
Apparatus 3 |
Reciprocating Cylinder |
6-35 |
Controlled release, Chewable tablets |
Apparatus 4 |
Flow through cell apparatus |
N/A |
Extended release, poorly soluble API tablets, Granules, Microparticle, Implants |
Apparatus 5 |
Paddle Over Disk |
25-50
|
Transdermal |
Apparatus 6 |
Rotating Cylinder |
N/A
|
Transdermal |
Apparatus 7 |
Reciprocating Holder |
30 |
CR ( non disintegrating oral and transdermal ) |
7.1 Basket Type 1 Appratus
The basket method, created in 1968 by Parmakoski and colleagues, is a closed-system procedure used for determining dissolution of drugs with significant water solubilities, utilizing minimal agitation and examining various medications. Examples of medications examined using this method include: – [11]
Tablets : Lithium carbonate tablets USP
Phenylbutazone tablets USP
Capsules : Extended phenytoin sodium capsules USP Methaqualone hydrochlorides capsules.
The equipment consists of a generator, rotating shafts, cylindrical baskets, and a glass vessel, maintained at 37°0.5°C. The bath liquid is stirred in a rotating basket technique, easy to standardize and reliable. The USP container method is preferred for assessing oral solid dosage forms with instantaneous release.[12]
Procedures:
ADVANTAGES:
DISADVANTAGES:
Applications:
7.2 Paddle Type 2 Appratus
Levy and Hayes' device may have been regarded as the forerunner of the beaker technique.[14] A cylinder is a cylindrical object made of optically clear materials, with an inside diameter of 98-106 mm and a capacity of 1000 ml.[15] The apparatus from Apparatus 1 is used for stirring, except for a paddle with a blade fixed on a shaft. The shaft should rotate smoothly and cross through the axis to ensure flush bottoms. The paddle and drive shaft are one unit, and a two-piece removable structure can be used if securely engaged.[16] Drugs that are poorly soluble in water are generally advised to use Equipment 2. More challenging circumstances are given by this device to yield faster outcomes. It takes a lengthy time for instruments 1 to finish the test for these medications. The medications that this kind of testing looks at are – [11]
Procedures:
ADVANTAGES:
DISADVANTAGES:
APPLICATIONS:
7.3 Reciprocating Cylinder Type 3 Apparatus
The release of drugs studies from delayed let go quick release, and beaded formulations is the objective of Apparatus 3. It works well with chewable tablets as well. This can be particularly helpful when the procedure for testing calls for a number of PH/buffer adjustments. Another name for it is "Bio-Disc."[11] The equipment includes glass vessels with smooth, cylinder-shaped bottoms, reciprocating cylindrical objects, metallic parts (type 316 or similar), suitable displays, an electric motor, and an assembly that rotates the cylinders upwards.[16] At a predetermined time, each cylinder can also be automatically switched to another medium. The next concept is the revolving container devices, which allows for media exchange to create feeding and fasting situations or a pH gradient.[17] The company encourages its usage in testing extended-release amount mixtures and enables automated evaluation for up to six days. It is suggested for the assessment of extended-release products that is apparatus 3 in USP 22.[18]
Procedures:
ADVANTAGES:
DISADVANTAGES:
Applications:
7.4 Flow Through Cell Type 4 Apparatus
The dissolution efficiency of the capsules and coated in sugar tablets is measured using apparatus 4. Patches, soft gelatin with water capsule-like structures, semi-solids, powdered materials, pellets, and injections are additional alterations.[11] Place the crystal beads in the monograph's appropriate compartment. Install the filter head after putting a single administration dose on front of each of the pellets or, if specified in the publication, on a metallic carrier. Then, use a suitable fastening mechanism to hold the components together.[19] The finite placements of the proportion investors, that also reduce as the quantity of sample material to be collected rises, further restrict the amount time periods that can be assembled.[20]
Proceduures:
ADVANTAGES:
DISADVANTAGES:
Applications:
7.5 Paddle Over Disk Type 5 Apparatus
The exception of an aluminium plate structure at the bottom inside the container for storing the epidermal structure, the design is identical to that of USP apparatus 2. Pretesting equipment, if they interfere with or interact with the sample being tested. The purpose of this plate assemblage is to decrease the quantity of "deceased" space above the storage device arrangement and the container's bottom. The mechanism is round and oriented so that its opening area was equal to the paddles cutting bottom caused by the disk's shape.[13]
Procedures:
ADVANTAGES:
DISADVANTAGES:
Applications:
Figure No 8 : Paddle Over Disk
7.6 Rotating Cylinder Type 6 Apparatus
The exception of the use of a stainless steel cylinder mixing component placed on top of the basket and shaft, and the construction is identical as that of USP Instrument 1. The apparatus's purpose is to load the material being tested into the cylinder at the starting point of each test, to ensure the long direction of the system fit within the cylinders's diameter or takes away air trapped in molecules. After inserting the chamber into the device, rotate it at the speed recommended by this particular monographs.[13]
Procedures:
ADVANTAGES:
DISADVANGES:
Applications:
7.7 Reciprocating Holder (USP 7 Apparatus)
After USP offered the smaller-volume option of small patches that were transdermal, the reciprocating disk instruments was renamed the reciprocating holder apparatus. A set of glass or another appropriate inert material measured corrected sampling containers as well, a motor and drives that rotate vertical to the system, along with a pair of proper sample containers make up the equipment. appropriate water bath of any practical size is used to partially submerge the sample containers. Attach all the systems to be examined to an appropriate sample container for the covered tablets that delivers the medication. 32 degrees Celsius throughout the test.[21]
Procedures:
ADVANTAGES:
DISADVANTAGES:
Applications:
CONCLUSION:
Dissolution testing aims to ensure the pharmaceutical stability of the product, involving not only its capacity to be developed continuously and the drug's ability to preserve its release correctly throughout the duration of its self-life, but also the dependability of the product's biopharmaceutical characteristics, including its rate and degree of absorption. Therefore, it would be ideal to create dissolving assays that can analyze a dosage form's ability of dissolving the substance adequately while also estimating the product's performance in vivo. In order to guarantee the effectiveness and quality of pharmaceutical dosage forms, the dissolution instruments utilized in the USP and Indian Pharmacopoeia (IP) is essential. By simulating in vitro settings, these devices enable the assessment of how medications release their active constituents over a period of While the types and specifications of IP and USP devices vary to meet local regulations, both are standardized to produce accurate and repeatable findings. Comprehending these approaches is crucial for the creation and quality assurance of reliable, secure, and efficient pharmaceuticals across the globe.
ACKNOWLEDGMENT:
With deep appreciation, we would like to thank everyone who helped make our review on in-vitro dissolution apparatus a success. Above all we would like to express our sincere gratitude to the management and faculty of Loknete Dr. J. D. Pawar College Of Pharmacy, Manur, Kalwan, for providing the necessary facilities and support to conduct of review, as well as to guide for your unwavering supports.
REFERENCES
Vanita Deore*, Nisha Deshmukh, Deepali Borade, Janhavi Darunte, Dr. Rajendra K. Surawase, A Review on In-Vitro Dissolution Apparatus, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 2, 658-671. https://doi.org/10.5281/zenodo.14844358